Halozyme Therapeutics shares owned by Cabot Money Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Cabot Money Management
from 13F filings
Historical chart of Cabot Money Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Cabot Money Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Cabot Money Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.8M | 67k | 57.24 |
| 2024-06-30 | $3.5M | 67k | 52.36 |
| 2024-03-31 | $2.7M | 67k | 40.68 |
| 2023-12-31 | $2.4M | 66k | 36.96 |
| 2023-09-30 | $1.8M | 46k | 38.20 |
| 2023-06-30 | $1.6M | 44k | 36.07 |
| 2023-03-31 | $1.8M | 48k | 38.19 |
| 2022-12-31 | $2.8M | 49k | 56.90 |
| 2022-09-30 | $1.3M | 33k | 39.54 |